ame-maschinen.ru


Crdl Price Target

Stock Price Target. No data provided. CRDL will report FY earnings on 03/27/ Yearly Estimates. High– Low– The target price for Cardiol Therapeutics (CRDL) stock is $, which is % above the current price of $ This is an average based on projections from. 6 Wall Street research analysts have issued 1-year price targets for Cardiol Therapeutics' stock. Their CRDL share price targets range from $ to $ Analyst Recommendations on Cardiol Therapeutics Inc. · Canaccord Genuity Adjusts Price Target on Cardiol Therapeutics to $8 From $6, Maintains Buy Rating · HC. CRDL | Complete Cardiol Therapeutics Inc. stock news by MarketWatch. View Cardiol Therapeutics Inc. Watchlist. Alert. NEW. Set a price target alert. OK.

Canaccord Genuity analyst Edward Nash maintains Cardiol Therapeutics (NASDAQ:CRDL) with a Buy and raises the price target from $6 to $8. BenzingaMay 23 Wall Street analysts forecast CRDL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CRDL. View Cardiol Therapeutics Inc. Class A CRDL stock quote prices, financial information, real-time forecasts, and company news from CNN. Cardiol Therapeutics (CRDL) reported Q1 earnings per share (EPS) of -$, meeting estimates of -$ by %. In the same quarter last year, Cardiol. Find the latest Cardiol Therapeutics Inc Class A (CRDL) stock forecast, month price target, predictions and analyst recommendations. Stock Price Forecast. The 3 analysts with month price forecasts for CRDL stock have an average target of , with a low estimate of and a high. According to 2 Wall Street analysts that have issued a 1 year CRDL price target, the average CRDL price target is $, with the highest CRDL stock price. Wall St. Analysts Ratings & Price Target. Follow K followers. $ (%) PM 04/05/ NASDAQ | $USD | Post-Market: $ + (+%). %. Percent of Float, %. Analyst Ratings. Average price target from 4 ratings: $ Average score: Sell. Under. Hold. Over. Buy. Full Ratings. What is the Cardiol Therapeutics Inc. stock forecast? The Cardiol Therapeutics Inc. stock forecast for tomorrow is $ , which would represent a %. Based on the Cardiol Therapeutics Inc Class A stock forecast from 1 analysts, the average analyst target price for Cardiol Therapeutics Inc Class A is CAD.

Cardiol Therapeutics Inc Class A Stock Forecast, CRDL stock price prediction. Price target in 14 days: USD. The best long-term & short-term Cardiol. Based on analysts offering 12 month price targets for CRDL in the last 3 months. The average price target is $ with a high estimate of $10 and a low. Volatile ride for Cardiol Therapeutics Inc. Class A stock price on Wednesday moving between $ and $ (Updated on Jun 26, ) · ame-maschinen.ru Signals &. Latest Analyst Research & Price Targets for Cardiol Therapeutics Inc (CRDL-T). According to analysts, CRDL price target is CAD with a max estimate of CAD and a min estimate of CAD. Check if this forecast comes true in a. CRDL Cardiol Therapeutics · High. · Low. · Volume. K · Open. · Pre Close. · Turnover. K · Turnover Ratio. % · P/E (Static). The 7 analysts offering price forecasts for Cardiol Therapeutics have a median target of , with a high estimate of and a low estimate of The. The Cardiol Therapeutics Inc. stock forecast for tomorrow is $ , which would represent a % loss compared to the current price. In the next week. Cardiol Therapeutics Inc Class A (CRDL) stock price prediction is USD. The Cardiol Therapeutics Inc Class A stock forecast is.

CRDL Cardiol Therapeutics · High. · Low. · Volume. K · Open. · Pre Close. · Turnover. K · Turnover Ratio. % · P/E (Static). The average one-year price target for Cardiol Therapeutics Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price target. Cardiol Therapeutics Inc has a consensus price target of $, established from looking at the 9 latest analyst ratings. The last 3 analyst ratings were. Wall St. Analysts Ratings & Price Target. Follow K followers. $ (%) PM 04/05/ NASDAQ | $USD | Post-Market: $ + (+%). Cardiol Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ame-maschinen.ru updated stock price target summary.

Find the latest Cordel Group PLC (CRDL) stock forecast, month price target, predictions and analyst recommendations. Cardiol Therapeutics (CRDL) reported Q1 earnings per share (EPS) of -$, meeting estimates of -$ by %. In the same quarter last year, Cardiol. (NASDAQ: CRDL) Cardiol Therapeutics stock price per share is $ today (as of May 29, ). What is Cardiol Therapeutics's Market Cap. 1 Year Target. $ Today's High/Low. $/$ Share Volume. , Here's Why You May Invest in Cardiol Therapeutics (CRDL) Stock. Sep 27, •. Discover Cardiol Therapeutics' earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. CRDL Long2+ r/r for the first target, another complex pullback trade, looks straight forward, will be looking to take it at open. Canaccord Genuity analyst Edward Nash maintains Cardiol Therapeutics (NASDAQ:CRDL) with a Buy and raises the price target from $6 to $8. BenzingaMay 23

dollar sign confetti | bee mining app


Copyright 2019-2024 Privice Policy Contacts